Home - The Pharma Navigator

The Executive Briefing

Daily institutional intel on the biotech market, delivered at 8:00 AM EST.

Browse by topics

THE BIG READ Serán Bioscience Secures Investment to Expand Commercial Manufacturing

4 min read • 3 weeks ago

The investment, led by Biospring Partners, will support Serán Bioscience’s expansion into commercial-scale production and state-of-the-art manufacturing facilities in Bend, Oregon.

Expansion Circio Raises Funds to Advance in vivo CAR-T Program
The Norwegian biotech plans to use the raised capital to expand its circular RNA platform and secure complementary…
Expansion Northway Biotech Expands CGMP Cell-Based Manufacturing
The Lithuanian CDMO has opened a new facility in Vilnius that can support advanced and personalized therapies, including…
Expansion Codis Expands European Footprint with Catalent Nottingham Facility Acquisition
By combining Nottingham’s development capabilities with its expanded Haverhill site, Codis creates an integrated UK pathway spanning early-stage…

THE BIG READ Nanoform Highlights CESS Benefits Versus Spray-Dried ASDs

4 weeks ago

According to the company, its commercial-scale nanoparticle manufacturing technology could reduce production costs and solvent use while increasing drug loading.

Discovery & Development Moonwalk Biosciences Closes Oversubscribed Series B Financing Round
The company has managed to raise USD 70 million, which it will use to progress its lead candidate…
Discovery & Development MedPharm Gains Olink Certification to Introduce Proteomic Analysis Services
Through this certified status, the CDMO will be able to offer its customers targeted, multiplex protein biomarker analysis…
Discovery & Development EyePoint Positions DURAVYU as a Potential Treatment for Wet AMD
Although the trial did not meet its primary endpoint, EyePoint reported a 42% reduction in overall treatment burden,…

THE BIG READ Bridging the Pipeline Gap

5 min read • 3 weeks ago

With the rise of increasingly complex biologics, innovators are leaning toward specialized service providers to bridge the gap between early breakthrough science and commercial manufacturing reality.

Discovery & Development CPHI Milan 2026: Connecting Supply Chains, Digital Innovations, and Sustainability
Ahead of CPHI Milan, Event Director Tara Dougal shares insights on the key themes, new dedicated zones, and…
Discovery & Development CPHI Milan 2026: Balancing Viscosity, Compliance, and Sustainability in Fill/Finish
Ahead of CPHI Milan 2026, Professor Hanns-Christian Mahler from ten23 health, explores how expanding dose volumes, flexible CDMO…
Discovery & Development CPHI Milan 2026: Overcoming Formulation Barriers in LAIs
As demand for patient-centric chronic disease treatments grows, Nanexa CTO Mårten Rooth discusses how atomic layer deposition enables…

THE BIG READ Lifecore Biomedical Signs Major Commercial Site-Transfer Deal

4 weeks ago

The Minnesota injectables CDMO has signed a technical transfer and manufacturing agreement for a currently marketed, high-viscosity injectable, marking its seventh late‑stage commercial program and 11th pipeline addition…

Dealmaking Novo Nordisk Secures Global License to Nanexa’s ALD Drug Delivery Platform
A global licensing agreement worth up to EUR 1.165 billion will leverage Nanexa's PharmaShell technology to develop long-acting…
Dealmaking Lifecore Biomedical Signs Major Commercial Site-Transfer Deal
The Minnesota injectables CDMO has signed a technical transfer and manufacturing agreement for a currently marketed, high-viscosity injectable,…
Dealmaking Lilly to Acquire Merida Biosciences for Antibody-Degradation Technology
Through this acquisition, Eli Lilly will strengthen its immunology capabilities by gaining access to a first-in-class antibody-degradation platform…

THE BIG READ Roche Gets Nod from European Commission for Susvimo

1 month ago

The European Commission has approved the ranibizumab 100 mg/mL injectable solution (Susvimo) from Roche as a treatment of neovascular age-related macular degeneration.

Regulatory Camizestrant Combination for Metastatic Breast Cancer Gains FDA Approval
The U.S. regulatory body has approved AstraZeneca’s Etcamah in combination with CDK4/6 inhibitors, to treat adults with HR‑positive,…
Regulatory Weekly HIV Pill Advances Toward Regulatory Submission
A combination therapy from Gilead and Merck has met its clinical efficacy endpoint, demonstrating non-inferiority to existing daily…
Regulatory FDA Extends Review of AstraZeneca’s Camizestran
AstraZeneca’s camizestrant has faced a regulatory setback in the U.S., with the FDA extending its review, seeking clearer…

THE BIG READ Codis Appoints Steven Facer in New Role as Chief Commercial Officer

1 month ago

The newly created role will bring the CDMO’s sales, marketing, and business development teams under a unified commercial strategy across the U.S. and UK.

Funding & Investments Building a Value-Driven Platform
SPONSORED CONTENT: As the biopharmaceutical landscape increasingly demands integrated technical operations, GCCs are expanding beyond back-office efficiency, reveals…
Funding & Investments Closing the Bioprocessing Gap
As the divide between upstream output and downstream capability in bioprocessing expands, it is becoming necessary for the…
Funding & Investments Overcoming the Hurdles to Oral Peptide Development
Experts from Alcami break down the latest innovations in lipid-based permeation matrices, continuous direct compression, and advanced analytical…